Rett Syndrome Research Trust
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rett Syndrome Research Trust sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Rett Syndrome Research Trust: 5 sponsored US clinical trials, 2 recruiting.
Rett Syndrome Research Trust sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Rett Syndrome, with 3 trials.
Upper-quartile sponsor footprint
Rett Syndrome Research Trust sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Validating Innovative Biosensors for Rett Autonomic Symptom Tracking
NCT06338267
The Rett Syndrome Global Registry
NCT04900493
Development of the ORCA Communication Measure for Rett Syndrome
NCT04920110
ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME
NCT04514549
A Study to Evaluate Ketamine for the Treatment of Rett Syndrome
NCT03633058
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Rett Syndrome Research Trust pipeline
2 recruiting of 5 indexed (40% open); 3 completed (60%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Rett Syndrome (3 trials), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rett Syndrome Research Trust: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
Rett Syndrome Research Trust sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this Rett Syndrome Research Trust page
5 registered trials is a research-attention snapshot, not an endorsement of Rett Syndrome Research Trust or any single study.
- 2 of Rett Syndrome Research Trust's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Rett Syndrome is the condition Rett Syndrome Research Trust studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rett Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rett Syndrome Research Trust pipeline card: 5 registered trials from official public datasets.Report a data error.